IVERIC bio Current Assets

IVERIC bio (ISEE) currently reports a current assets of $610M as of March 2023. That compares with $350M in the prior-year period — up 74.2% year over year. Use the charts on this page to explore IVERIC bio's current assets history and peer comparisons.

IVERIC bio's current assets increased from $350M to $610M — a 74.2% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IVERIC bio reported $610M in current assets as of March 2023. That compares with $350M in the prior-year period — up 74.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $610M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IVERIC bio, and consider following ISEE for alerts when major investors trade the stock.

IVERIC bio is classified in the Healthcare sector. On current assets, it currently shows $610M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ISEE with unrelated industries.